RNU7-69P

Across TCGA pan-cancer cohorts, RNU7-69P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU7-69P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RNU7-69P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-69P expression acts as an unfavorable survival marker.

THCA, UCS, and HNSC are the cancer types where RNU7-69P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.711	0.942	<.001	54	view →
UCS	DFS	Tertile	III,IV	0.120	0.441	.004	36	view →
HNSC	DFS	Tertile	III,IV	0.050	0.611	<.001	36	view →
LGG	OS	Tertile	All	0.132	0.830	<.001	36	view →
LIHC	OS	Tertile	All	0.061	0.783	<.001	33	view →
STAD	OS	Tertile	III,IV	0.201	0.538	.025	27	view →
BLCA	OS	Tertile	IV	0.234	0.606	.005	18	view →
KIRC	DFS	Tertile	IV	0.127	0.630	.039	18	view →
TGCT	DFS	Tertile	All	0.014	0.837	<.001	18	view →
KIRP	OS	Tertile	All	0.580	0.903	.010	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU7-69P–THCA (OS)

Open the THCA breakdown →